Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01597388
Title AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications

breast cancer

Therapies

Fulvestrant + Vistusertib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Sarasota Florida 34232 United States Details
Research Site Detroit Michigan 48201 United States Details
Research Site Oklahoma City Oklahoma 73104 United States Details
Research Site Greenville South Carolina 29605 United States Details
Research Site Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field